Study to Evaluate Use of Albuterol Multidose Dry Powder Inhaler With an eModule in Participants With Asthma

Study Title
A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma
Teva Identifier
ABS-AS-30064
ClinicalTrials.gov Identifier
NCT02969408
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol Sulfate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years and older
Trial Duration
February 13, 2017 - February 2, 2018
Phase
Phase 3

Study Type

Interventional